1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. New Jersey >
  7. ADMA Biologics >
  8. M&A

ADMA Biologics Mergers & Acquisitions

ADMA Biologics M&A Summary

ADMA Biologics has acquired 1 company.

ADMA Biologics’ largest acquisition to date was in 2017, when it acquired Biotest Pharmaceuticals - US Therapy Business for $40M. ADMA Biologics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

ADMA Biologics

ADMA Biologics, Inc.

465 State Route 17,
Ramsey, New Jersey 07446
United States,
(201) 478-5552
www.admabiologics.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2017-01-23 Biotest Pharmaceuticals Corp. - US Therapy Business · Life Science
, United States

Biotest Pharmaceuticals Corp. - US Therapy Business Includes the assets of BPC’s plasma fractionation facility, its commercial products, contract manufacturing agreements as well as BPC’s Boca Raton, Florida headquarters and real properties.

40 Divestiture

ADMA Biologics
Advisors: Paul, Weiss, Rifkind, Wharton & Garrison , PJT Partners , Raymond James - Investment Banking

Biotest Pharmaceuticals Corp.
Advisors: Credit Suisse Investment Banking , GreenbergTraurig


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal